Allied BioNutrition’s Nutraceutical biotechnology focuses on revolutionary science that may impact the lives of millions of people worldwide. Our biotechnology utilizes a clinically-based, field-proven, proprietary flavonoids extract from the polyphenol family which features unmatched antioxidation characteristics uniquely formulated for cardiovascular health.
After years of research and clinical trials, we were able to demonstrate and clinically validate the high efficacy of our biotechnology on LDL cholesterol oxidation and its drastic impact on arterial health and blood circulation as well as other cardiovascular parameters that are critical to our health.
Allied BioNutrition’s biotechnology truly presents a clinically proven “think-out- of-the- box” approach to cardiovascular health management.
Study Results: Flavonoids Root Extract Reduces Oxidation
In April 2016, the results from our double-blind, placebo-controlled study were published in the scientific journal Food and Nutrition Research. The study examined the effect of our unique Flavonoids Root Extract on the thickness of the artery wall (carotid intima-media thickness or CIMT) in individuals with oxidation in the arteries. CIMT is considered a strong biomarker of overall cardiovascular and arterial health.
People with increased oxidation in the arteries, total cholesterol greater then 240mg/dL, were randomly allocated to 2 groups as follows: an experimental group that received 200mg of the flavonoids root extract and a placebo group. 110 participants were initially allocated to the 2 groups. After some withdrawals, 94 subjects ultimately completed the trial. After 1 year, the study yielded the following results:
In the experimental group the thickness of artery (CIMT) decreased from 0.92 mm to 0.84 mm. In the placebo group CIMT increased from 0.85 to 0.88.
In the experimental group total cholesterol decreased from 284 to 262 mm/dL. In the placebo group total cholesterol decreased from 291 to 289mm/dL.
In the experimental group the LDL (bad) cholesterol decreased from 183 to 173 mm/dL. In the placebo group the LDL (bad) cholesterol increased from 177 to 179.
HDL or good cholesterol did not change in either group.
In the experimental group systolic blood pressure decreased from 138 to 125mmhg. In the placebo group systolic blood pressure increased from 136 to 137.
In the experimental group diastolic blood pressure decreased from 92 to 84. In the placebo group diastolic blood pressure increased from 89 to 90.
These results were extremely compelling. Following one year of Flavonoids Root Extract consumption, mean CIMT, total cholesterol, LDL levels, and blood pressure decreased. This suggests that this ingredient may attenuate the development of oxidation and of related cardiovascular problems.
Pilot Market Sees Great Success
In 2016, Allied BioNutrition announced its Nutraceutical biotechnology consisting of a proprietary Flavonoids Root Extract. This extract has unmatched antioxidant properties that has been clinically validated for its cardiovascular health benefits. It has been successfully used by thousands of consumers over many years in a predetermined pilot market. Most of these consumers used this proprietary Flavonoids Root Extract on a daily basis and experienced profound cardiovascular health benefits. In 2017, Allied BioNutrition will officially launch a growing family of Nutraceutical dietary supplements, bringing this extraordinary Flavonoids antioxidant biotechnology, with all its unique cardiovascular health benefits, to the world.
The Origins of Our Proprietary Flavonoids Root Extract
A team of prominent Israeli scientists in the areas of oxidative stress and antioxidants focusing on dietary polyphenols and paraoxonases were the first to elucidate the mechanisms behind the protection against plasma oxidation. This was first shown by the consumption of red wine or pomegranate juice (POM), and then through the cardio-protection of the antioxidant enzyme, paraoxonases (PON), which breaks down harmful oxidized lipids.
After several years of research, the Israeli research team discovered that Flavonoids Root Extract, formulated via a unique process from the roots of the Glycyrrhiza Glabra plant, can reduce LDL cholesterol oxidation in the blood of humans by 55%, as well as provides a wide range of cardiovascular health benefits.
Allied BioNutrition took these discoveries one step further. Our 2016 clinical trial revealed that this unique Flavonoids extract may contribute not only to a significant reduction of LDL oxidation in plasma, but goes beyond that and promotes removal of oxidized cholesterol that has accumulated over years in the arteries. This is a major step forward in promoting cardiovascular health and, in particular, heart health.